The WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee has released a statement following the review of a small number of cases of myocarditis reported in individuals who have received COVID-19 mRNA vaccines.
Cases have predominantly been reported in adolescents and young adults, with a typical symptom onset occurring within 4 days of vaccination. Reports were more common following receipt of a second dose of the vaccine. GACVS notes that most cases of myocarditis appear to be mild.
The COVID-19 subcommittee reiterates that the benefit of vaccination in reducing deaths and hospitalisations due to COVID-19 disease outweighs potential risk of vaccine side effects.
要阅读更多信息，请点击以下链接：